1. Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro‐resected patient. (4th May 2017) Authors: Taibi, C.; Tempestilli, M.; D'Avolio, A.; Garbuglia, A. R.; De Nicolò, A.; Montalbano, M.; D'Offizi, G. Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 42:Number 5(2017) Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of DAA therapy on health-related quality of life in liver transplanted patients. Is there a role for ribavirin?. (10th February 2016) Authors: Lionetti, R.; Palummieri, A.; Taibi, C.; Medici, E.; Montalbano, M.; Visco Comandini, U.; Loiacono, L.; Puro, V.; Ettorre, G.M.; Giulianelli, M.; D'Offizi, G. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis. Issue 1 (February 2018) Authors: Masetti, C.; Lionetti, R.; Lupo, M.; Siciliano, M.; Giannelli, V.; Ponziani, F.R.; Teti, E.; Dell'Unto, C.; Francioso, S.; Brega, A.; Montalbano, M.; Visco-Comandini, U.; Taibi, C.; Galati, G.; Gentilucci, U. Vespasiani; Picardi, A.; Andreoni, M.; Pompili, M.; Pellicelli, A.M.; D'Offizi, G. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Overall survival and incidence of liver-related events in a cohort of cirrhotic patients treated with direct antiviral agents: results from a multicenter study. (February 2019) Authors: Masetti, C.; Marignani, M.; Lionetti, R.; Gentilucci, U. Vespasiani; Santopaolo, F.; Milana, M.; Begini, P.; Taibi, C.; Galati, G.; Comandini, U. Visco; D'Offizi, G.; Angelico, M. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The Fibrosis-4 index is associated with Intensive Care Unit (ICU) admission in middle-aged patients with COVID-19. (March 2021) Authors: Biliotti, E.; Piselli, P.; Visco Comandini, U.; Lionetti, R.; Taibi, C.; Vincenzi, L.; Moghazi, S. Al; Antinori, A.; Caraffa, E.; Cimaglia, C.; Marchioni, L.; Mariano, A.; Mastrorosa, I.; Mosti, S.; Navarra, A.; Nicastri, E.; Palmieri, F.; Girardi, E.; D'Offizi, G.; Study Group, ReCOVeRI Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗